Borderline Personality Disorder Clinical Trial
— mDIARYOfficial title:
The mDIARY Study: Using Smartphones for Daily Selfmonitoring of Skilluse and Outcome in Dialectical Behavior Therapy With Borderline Personality Disorder: A Combined RCT and Timeseries Study
Verified date | November 2019 |
Source | Region of Southern Denmark |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
BACKGROUND: Borderline Personality Disorder (BPD) is a serious and debilitating mental
disease characterized by difficulties with emotion regulation that leads to unstable and
self- destructive behavior and relationships. The prevalence of BPD is between 1% and 5% in
the Scandinavian population with similar prevalence rates found in US epidemiologic surveys.
BPD increases the risk for suicide by 4-fold, while patients with comorbid BDP and tendency
to self-harm have a further 2-fold attenuated risk. BDP is difficult to treat, and even more
difficult when co-occurring with other disorders. Dialectical Behavior Therapy (DBT) is the
best validated treatment for BPD, showing medium to large effect sizes as compared to
treatment as usual for anger, parasuicidality (suicide attempts without an intention to die)
and poor mental health. DBT uses self-monitoring as the mainstay of treatment, which helps
patients regulate their emotions by means of emotional regulating skills, and reduce problem
behavior. Self-monitoring has traditionally been done by means of daily paper diaries. The
latest developments in smartphone applications have generated alternatives for ecological
momentary assessments of problematic behavior that even prompt patients to practice skills
targeting emotion regulation. An example of this is Monsenso's DBT self-monitoring mHealth
application (mHealth means mobile health, public health supported by mobile phones). Such
applications may enhance treatment success in BPD patients, as they are available to patients
at all times.
OBJECTIVES: To evaluate the Monsenso's mHealth app with respect to clinical efficacy as an
adjunct to DBT-psychotherapy treatment and utility as a way to measure outcomes in BPD
patients.
METHODS: The study will be a 2-year multi center, randomized controlled trial. In both
conditions patients will be followed for one year. Self report data of DBT-skills-use,
positive and negative affect, Standardised self report questionnaires on Emotion regulation
ability; functioning; borderline symptoms. will be given pre, post and every month. The
treatment arm (n=50) will receive the mHealth app that includes coaching suggestions and
instructed how to use it. The control arm (n=50) will only use a pen and paper based
self-monitoring, as traditionally used in DBT-treatment.
STUDY ENDPOINTS: Primary: mean number of days passed per new DBT-Skill learned. Secondary:
Borderline personality disorder(BPD)-symptoms, Emotion regulation ability, ratio
positive/negative affect.
Status | Active, not recruiting |
Enrollment | 78 |
Est. completion date | April 30, 2020 |
Est. primary completion date | December 30, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Must be admitted to DBT treatment at a psychiatric hospital treatment facility in Denmark - Must meet the criteria for Emotionally unstable personality disorder - Must be 18 yr.o. Exclusion Criteria: - Psychosis - Schizophrenia - Bipolar disorder - IQ under 70 - Patients who do not have a working smartphone - Demographic data on rejected patients will be collected |
Country | Name | City | State |
---|---|---|---|
Denmark | Glostrup DAT team. Psykiatrisk Ambulatorium | Copenhagen | Brøndby |
Denmark | Haderslev DAT team | Haderslev | |
Denmark | Silkeborg DAT team, Psykiatriens Hus | Silkeborg | |
Denmark | Lokalpsykiatrisk ambulatorium | Svendborg | |
Denmark | Vejle DAT- team, Psykiatrisk ambulatorium | Vejle |
Lead Sponsor | Collaborator |
---|---|
Region of Southern Denmark | Central Denmark Region, Innovation Fund Denmark, Mclean Hospital, Monsenso APS, Denmark, University of Southern Denmark |
Denmark,
Bedics JD, Atkins DC, Comtois KA, Linehan MM. Weekly therapist ratings of the therapeutic relationship and patient introject during the course of dialectical behavioral therapy for the treatment of borderline personality disorder. Psychotherapy (Chic). 2012 Jun;49(2):231-40. doi: 10.1037/a0028254. — View Citation
Burke LE, Styn MA, Sereika SM, Conroy MB, Ye L, Glanz K, Sevick MA, Ewing LJ. Using mHealth technology to enhance self-monitoring for weight loss: a randomized trial. Am J Prev Med. 2012 Jul;43(1):20-6. doi: 10.1016/j.amepre.2012.03.016. — View Citation
Faurholt-Jepsen M, Frost M, Ritz C, Christensen EM, Jacoby AS, Mikkelsen RL, Knorr U, Bardram JE, Vinberg M, Kessing LV. Daily electronic self-monitoring in bipolar disorder using smartphones - the MONARCA I trial: a randomized, placebo-controlled, single-blind, parallel group trial. Psychol Med. 2015 Oct;45(13):2691-704. doi: 10.1017/S0033291715000410. Epub 2015 Jul 29. — View Citation
Faurholt-Jepsen M, Vinberg M, Frost M, Christensen EM, Bardram JE, Kessing LV. Smartphone data as an electronic biomarker of illness activity in bipolar disorder. Bipolar Disord. 2015 Nov;17(7):715-28. doi: 10.1111/bdi.12332. Epub 2015 Sep 23. — View Citation
Klein AS, Skinner JB, Hawley KM. Targeting binge eating through components of dialectical behavior therapy: preliminary outcomes for individually supported diary card self-monitoring versus group-based DBT. Psychotherapy (Chic). 2013 Dec;50(4):543-52. doi: 10.1037/a0033130. — View Citation
Linehan MM, Comtois KA, Murray AM, Brown MZ, Gallop RJ, Heard HL, Korslund KE, Tutek DA, Reynolds SK, Lindenboim N. Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry. 2006 Jul;63(7):757-66. Erratum in: Arch Gen Psychiatry. 2007 Dec;64(12):1401. — View Citation
Neacsiu AD, Eberle JW, Kramer R, Wiesmann T, Linehan MM. Dialectical behavior therapy skills for transdiagnostic emotion dysregulation: a pilot randomized controlled trial. Behav Res Ther. 2014 Aug;59:40-51. doi: 10.1016/j.brat.2014.05.005. Epub 2014 May 27. — View Citation
Stoffers JM, Völlm BA, Rücker G, Timmer A, Huband N, Lieb K. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2012 Aug 15;(8):CD005652. doi: 10.1002/14651858.CD005652.pub2. Review. — View Citation
Stone AA, Broderick JE, Schwartz JE, Shiffman S, Litcher-Kelly L, Calvanese P. Intensive momentary reporting of pain with an electronic diary: reactivity, compliance, and patient satisfaction. Pain. 2003 Jul;104(1-2):343-51. — View Citation
Torgersen S, Kringlen E, Cramer V. The prevalence of personality disorders in a community sample. Arch Gen Psychiatry. 2001 Jun;58(6):590-6. — View Citation
Torgersen S. [Paranoid schizophrenia, paranoid psychoses and personality disorders]. Tidsskr Nor Laegeforen. 2012 Apr 17;132(7):851-2. doi: 10.4045/tidsskr.12.0318. Norwegian. — View Citation
Turk MW, Elci OU, Wang J, Sereika SM, Ewing LJ, Acharya SD, Glanz K, Burke LE. Self-monitoring as a mediator of weight loss in the SMART randomized clinical trial. Int J Behav Med. 2013 Dec;20(4):556-61. doi: 10.1007/s12529-012-9259-9. — View Citation
* Note: There are 12 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Days/skill | Mean number of days required to learn a new DBT-skill | Daily measurements up to 1 year. (minimum 8 months.) | |
Secondary | Borderline symptoms | BPD symptoms according to the ZAN-BPD | Pre, post and monthly measurements up to 1 year (minimum 8 months) | |
Secondary | Ability to emotionally regulate | Emotion regulation ability according to the Kim Gratz DERS-scale | Pre, post and monthly measurements up to 1 year (Minimum 8 months) | |
Secondary | Compliance to self registration | Days of compliant registration | Daily measurements up to 1 year (minimum 8 months) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04856449 -
DBT Skills Plus EMDR for BPD and Trauma
|
N/A | |
Active, not recruiting |
NCT04587518 -
Five Factor Model Treatment for Borderline Personality Disorder
|
N/A | |
Recruiting |
NCT05651295 -
A Precision Medicine Approach to Target Engagement for Emotion Regulation
|
N/A | |
Completed |
NCT03677037 -
The Short-Term MBT Project
|
Phase 3 | |
Not yet recruiting |
NCT05989529 -
Delving Into Borderline Personality Disorder Clinical Trial Experiences
|
||
Completed |
NCT02518906 -
Evaluation of AIT Study
|
N/A | |
Completed |
NCT02068326 -
MBT in Groups for Adolescents With BPD or Subthreshold BPD Versus TAU - the M-GAB Randomized Controlled Trial
|
N/A | |
Recruiting |
NCT04296604 -
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
|
N/A | |
Terminated |
NCT02149823 -
Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations
|
Phase 1 | |
Completed |
NCT02108990 -
Acetaminophen and Social Processes
|
Phase 2 | |
Not yet recruiting |
NCT01683136 -
Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Feasibility Study for the Treatment of Borderline Personality Disorder
|
N/A | |
Completed |
NCT02988037 -
Adapted Dialectical Behaviour Therapy for Adolescents With Deliberate Self-Harm: A Pre-post Observational Study
|
N/A | |
Completed |
NCT01635556 -
Evaluation of a Modified Dialectical Behavior Therapy Program
|
N/A | |
Completed |
NCT02397031 -
Mindfulness and Interpersonal Effectiveness Skills in Borderline Personality Disorder
|
N/A | |
Terminated |
NCT01103180 -
Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder
|
Phase 2 | |
Terminated |
NCT01212588 -
Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD)
|
Phase 2 | |
Terminated |
NCT00539188 -
N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD
|
Phase 2 | |
Recruiting |
NCT05398627 -
Neurofeedback for Borderline Personality Disorder
|
N/A | |
Recruiting |
NCT03994510 -
SHame prOpensity in bOrderline Personality Disorder
|
N/A | |
Recruiting |
NCT06005129 -
Personality Change Study for Borderline Personality Disorder
|
N/A |